CAY10444是一种选择性 sphingosine-1-phosphate 3 (S1P3) 拮抗剂。它通过抑制 S1P3 受体介导的信号传导,减少 S1P 诱导的细胞钙离子流入。CAY10444 在研究心血管和免疫相关疾病中具有潜力。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | CAY10444 , also known as BML-241, is an S1P3 antagonist. CAY10444 inhibits the S1P-induced increase in Ca2+ by 37% in HeLa cells expressing the S1P3 receptor[1].BML-241 inhibited the increase in intracellular Ca2+ concentration induced by stimulation via P2 receptors or α1A adrenergic receptors and α1A adrenergic receptor-mediated constriction of rat mesenteric arteries without affecting the S1P3-mediated decrease in forskolin-induced cAMP accumulation[1]. |
| Concentration | Treated Time | Description | References | |
| bovine aortic endothelial cells (BAEC) | 10 µM | To evaluate the effect of CAY10444 on HDL-induced endothelial cell migration and Akt/eNOS phosphorylation, results showed that CAY10444 did not inhibit these responses. | Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1788-94 | |
| human retinal microvascular endothelial cells (HRMECs) | 1-100 μM | 10 h | CAY10444 suppressed S1P-induced tube-like vessel formation | Lab Invest. 2021 Feb;101(2):245-257 |
| human umbilical vein endothelial cells (HUVECs) | 10 μM | 24 h | CAY10444 downregulated VEGF-A and VE-cadherin mRNA expression | Lab Invest. 2021 Feb;101(2):245-257 |
| TKE2 corneal epithelial cells | 100 μM | 24 h | CAY10444 blocked S1P-induced increases in VEGF-A mRNA expression levels | Lab Invest. 2021 Feb;101(2):245-257 |
| human astrocytes (HAs) and hCMEC/D3 cells | 1 µM | 24 h | To evaluate the effect of S1PR3 on the blood-brain barrier. Results showed that S1P stimulation increased CCL2, p-p38 MAPK, and ICAM-1 expression and decreased ZO-1 expression, while CAY10444 treatment reversed this phenomenon. | CNS Neurosci Ther. 2021 Jun;27(6):674-686 |
| human monocyte derived macrophages (hMDM) | 10μM | 42 h | To study the effect of S1PR3 inhibition on ERK1/2 phosphorylation and parasite load. Results showed that CAY10444 pretreatment led to increased ERK1/2 phosphorylation and increased parasite load. | PLoS Negl Trop Dis. 2018 Aug 17;12(8):e0006647 |
| THP-1 derived macrophages (TDM) | 10μM | 42 h | To study the effect of S1PR3 inhibition on ERK1/2 phosphorylation and parasite load. Results showed that CAY10444 pretreatment led to increased ERK1/2 phosphorylation and increased parasite load. | PLoS Negl Trop Dis. 2018 Aug 17;12(8):e0006647 |
| rat sensory neurons | 10 μM | 30 min | CAY10444, as a selective antagonist for S1PR3, in combination with W146 (S1PR1 antagonist), blocked the S1P-induced enhancement of neuronal excitability. | J Neuroinflammation. 2015 Apr 12;12:70 |
| HAPI cells | 10 μM | 2 h | Inhibits S1P binding to S1PR3, reduces p38 MAPK phosphorylation and NF-κB p65 activation | J Neuroinflammation. 2021 Feb 18;18(1):50. |
| Administration | Dosage | Frequency | Description | References | ||
| Adult male Sprague Dawley rats | Collagenase-induced intracerebral hemorrhage model | Intraperitoneal injection | 0.5 mg/kg | Once daily for 1 or 3 days | To evaluate the effect of CAY10444 on brain edema, BBB integrity, and behavioral deficits after ICH. Results showed that CAY10444 significantly reduced brain edema volume, ameliorated BBB integrity, and improved behavioral deficits. | CNS Neurosci Ther. 2021 Jun;27(6):674-686 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.48mL 0.70mL 0.35mL |
17.39mL 3.48mL 1.74mL |
34.79mL 6.96mL 3.48mL |
|
| CAS号 | 298186-80-8 |
| 分子式 | C15H29NO2S |
| 分子量 | 287.46 |
| SMILES Code | O=C(C1NC(CCCCCCCCCCC)SC1)O |
| MDL No. | MFCD08062140 |
| 别名 | BML-241 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 40 mg/mL(139.15 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1